Leptospirosis: Pathogenesis, immunity, and diagnosis

Current Opinion in Infectious Diseases

Volumn 20, Issue 3, 2007, Pages 284-292

  Palaniappan, Raghavan U M ^a   Ramanujam, Subbupoongothai ^a   Chang, Yung Fu ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Diagnosis; Immunity; Leptospirosis; Pathogenesis

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; DNA VACCINE; IMMUNOGLOBULIN M ANTIBODY; INACTIVATED VACCINE; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 1; OUTER MEMBRANE PROTEIN LIPL41; RECOMBINANT VACCINE; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; ANTIBODY SCREENING; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELLULAR IMMUNITY; CHEMOTAXIS; COMPARATIVE GENE MAPPING; COMPUTER MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FUNCTION; GENE INDUCTION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GRAM NEGATIVE BACTERIUM; HIGH THROUGHPUT SCREENING; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; INNATE IMMUNITY; LEPTOSPIRA; LEPTOSPIROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEOMICS; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; SPIROCHETE; VACCINATION; VARIABLE NUMBER OF TANDEM REPEAT; VETERINARY MEDICINE;

ANIMALS; BACTERIAL VACCINES; HUMANS; LEPTOSPIRA; LEPTOSPIROSIS;

EID: 34247608279     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32814a5729     Document Type: Review

References (176)

1. Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14:296-326.
2. Faine S, Adher B, Bloin C, Perolat P. Leptospira and leptospirosis. 2nd ed. Melbourne, Australia: MedSci; 1999.
3. Kalsow CM, Dwyer AE. Retinal immunopathology in horses with uveitis. Ocul Immunol Inflamm 1998; 6:239-251.
4. Parma AE, Sanz ME, Lucchesi PM, et al. Detection of an antigenic protein of Leptospira interrogans which shares epitopes with the equine cornea and lens. Vet J 1997; 153:75-79.
5. Rathinam SR, Rathnam S, Selvaraj S, et al. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol 1997; 124:71-79.
6. de Souza AL, Sztajnbok J, Marques SR, Seguro AC. Leptospirosis-induced meningitis and acute renal failure in a 19-month-old male child. J Med Microbiol 2006; 55:795-797.
7. Meslin FX. Global aspects of emerging and potential zoonoses: a WHO perspective. Emerging infectious diseases 1997; 3:223-228.
8. Bulach DM, Zuerner RL, Wilson P, et al. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci USA 2006; 103:14560-14564.
9. Nascimento AL, Ko AI, Martins EA, et al. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol 2004; 186:2164-2172.
10. Ren SX, Fu G, Jiang XG, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003; 422:888-893.
11. Charon NW, Goldstein SF. Genetics of motility and chemotaxis of a fascinating group of bacteia: the spirochetes. Annu Rev Genet 2002; 36:47-73.
12. Bourhy P, Salaun L, Lajus A, et al. A genomic island of the pathogen Leptospira interrogans serovar Lai can excise from its chromosome. Infect Immun 2007; 75:677-683.
13. Zuerner RL, Knudtson W, Bolin CA, Trueba G. Characterization of outer membrane and secreted proteins of Leptospira interrogans serovar Pomona. Microb Pathog 1991; 10:311-322.
14. Cullen PA, Cordwell SJ, Bulach DM, et al. Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun 2002; 70:2311-2318.
15. Cullen PA, Haake DA, Bulach DM, et al. LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun 2003; 71:2414-2421.
16. Haake DA, Champion CI, Martinich C, et al. Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic Leptospira spp. J Bacteriol 1993; 175:4225-4234.
17. Haake DA, Chao G, Zuerner RL, et al. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun 2000; 68:2276-2285.
18. Haake DA, Martinich C, Summers TA, et al. Characterization of leptospiral outer membrane lipoprotein LipL36: downregulation associated with late-log-phase growth and mammalian infection. Infect Immun 1998; 66:1579-1587.
19. Haake DA, Matsunaga J. Characterization of the leptospiral outer membrane and description of three novel leptospiral membrane proteins. Infect Immun 2002; 70:4936-4945.
20. Haake DA, Mazel MK, McCoy AM, et al. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 1999; 67:6572-6582.
21. Matsunaga J, Barocchi MA, Croda J, et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 2003; 49:929-945.
22. Matsunaga J, Young TA, Barnett JK, et al. Novel 45-kilodalton leptospiral protein that is processed to a 31-kilodalton growth-phase-regulated peripheral membrane protein. Infect Immun 2002; 70:323-334.
23. Palaniappan RU, Chang YF, Hassan F, et al. Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA. J Med Microbiol 2004; 53:975-984.
24. Palaniappan RU, Chang YF, Jusuf SS, et al. Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans. Infect Immun 2002; 70:5924-5930.
25. Shang ES, Summers TA, Haake DA. Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun 1996; 64:2322-2330.
26. Shang ES, Exner MM, Summers TA, et al. The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin. Infect Immun 1995; 63:3174-3181.
27. Barnett JK, Barnett D, Bolin CA, et al. Expression and distribution of leptospiral outer membrane components during renal infection of hamsters. Infect Immun 1999; 67:853-861.
28. Nally JE, Artiushin S, Timoney JF. Molecular characterization of thermoinduced immunogenic proteins Q1p42 and Hsp15 of Leptospira interrogans. Infect Immun 2001; 69:7616-7624.
29. Nally JE, Whitelegge JP, Bassilian S, et al. Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect Immun 2007; 75:766-773. This report describes the proteome of leptospires during infection and lists several leptospiral proteins that are upregulated only during infection.
30. Yang CW, Wu MS, Pan MJ, et al. Leptospira outer membrane protein activates NF-κB and downstream genes expressed in medullary thick ascending limb cells. J Am Soc Nephrol 2000; 11:2017-2026.
31. Yang CW, Wu MS, Pan MJ, et al. The Leptospira outer membrane protein LipL32 induces tubulointerstitial nephritis-mediated gene expression in mouse proximal tubule cells. J Am Soc Nephrol 2002; 13:2037-2045.
32. Yang CW, Hung CC, Wu MS, et al. Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int 2006; 69:815-822. In this study leptospiral outer membrane proteins were used to induce an early inflammatory response in renal proximal tubule cells, which was found to be mediated by TLR2.
33. Verma A, Artiushin S, Matsunaga J, et al. LruA and LruB, novel lipoproteins of pathogenic Leptospira interrogans associated with equine recurrent uveitis. Infect Immun 2005; 73:7259-7266.
34. Verma A, Hellwage J, Artiushin S, et al. LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun 2006; 74:2659-2666. This report describes a novel H binding protein of pathogenic leptospires that contributes to the resistance of pathogenic leptospires to complement-mediated killing.
35. Merien F, Truccolo J, Baranton G, Perolat P. Identification of a 36-kDa fibronectin-binding protein expressed by a virulent variant of Leptospira interrogans serovar Icterohaemorrhagiae. FEMS Microbiol Lett 2000; 185:17-22.
36. Nascimento AL, Verjovski-Almeida S, Van Sluys MA, et al. Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res 2004; 37:459-477; Epub 2004 Mar 23.
37. Vinh T, Adler B, Faine S. Ultrastructure and chemical composition of lipopolysaccharide extracted from Leptospira interrogans serovar Copenhageni. J Gen Microbiol 1986; 132:103-109.
38. Shimizu T, Matsusaka E, Takayanagi K, et al. Biological activities of lipopolysaccharide-like substance (LLS) extracted from Leptospira interrogans serovar canicola strain Moulton. Microbiol Immunol 1987; 31:727-735.
39. Shimizu T, Matsusaka E, Nagakura N, et al. Chemical properties of lipopolysaccharide-like substance (LLS) extracted from Leptospira interrogans serovar canicola strain Moulton. Microbiol Immunol 1987; 31:717-725.
40. Nally JE, Chow E, Fishbein MC, et al. Changes in lipopolysaccharide O antigen distinguish acute versus chronic Leptospira interrogans infections. Infect Immun 2005; 73:3251-3260.
41. Saier M, Garcia-Lara J. The spirochetes: molecular and cellular biology. Wymondham, UK: Horizon Scientific Press; 2001.
42. Werts C, Tapping RI, Mathison JC, et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2:346-352.
43. Bulach DM, Kalambaheti T, de la Pena-Moctezuma A, Adler B. Functional analysis of genes in the rfb locus of Leptospira borgpetersenii serovar Hardjo subtype Hardjobovis. Infect Immun 2000; 68:3793-3798.
44. Bulach DM, Kalambaheti T, de la Pena-Moctezuma A, Adler B. Lipopolysaccharide biosynthesis in Leptospira. J Mol Microbiol Biotechnol 2000; 2:375-380.
45. de la Pena-Moctezuma A, Bulach DM, Adler B. Genetic differences among the LPS biosynthetic loci of serovars of Leptospira interrogans and Leptospira borgpetersenii. FEMS Immunol Med Microbiol 2001; 31:73-81.
46. de la Pena-Moctezuma A, Bulach DM, Kalambaheti T, Adler B. Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar Hardjo: Leptospira interrogans subtype Hardjoprajitno and Leptospira borgpetersenii subtype Hardjobovis. FEMS Microbiol Lett 1999; 177: 319-326.
47. Nahori MA, Fournie-Amazouz E, Que-Gewirth NS, et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J Immunol 2005; 175:6022-6031.
48. Viriyakosol S, Matthias MA, Swancutt MA, et al. Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun 2006; 74:887-895.
49. Arean VM, Sarasin G, Green JH. The pathogenesis of leptospirosis: toxin production by Leptospira icterohaemorrhagiae. Am J Vet Res 1964; 25: 836-843.
50. Lee SH, Kim S, Park SC, Kim MJ. Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells. Infect Immun 2002; 70:315-322.
51. Lee SW, Cooksey DA. Genes expressed in Pseudomonas putida during colonization of a plant-pathogenic fungus. Appl Environ Microbiol 2000; 66:2764-2772.
52. Finlay BB, Cossart P. Exploitation of mammalian host cell functions by bacterial pathogens. Science 1997; 276:718-725.
53. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994; 48:585-617.
54. Ballard SA, Williamson M, Adler B, et al. Interactions of virulent and avirulent leptospires with primary cultures of renal epithelial cells. J Med Microbiol 1986; 21:59-67.
55. Marshall RB. Ultrastructural changes in renal tubules of sheep following experimental infection with Leptospira interrogans serotype pomona. J Med Microbiol 1974; 7:505-508.
56. Vinh T, Faine S, Adler B. Adhesion of leptospires to mouse fibroblasts (L929) and its enhancement by specific antibody. J Med Microbiol 1984; 18:73-85.
57. Barocchi MA, Ko AI, Reis MG, et al. Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen. Infect Immun 2002; 70:6926-6932.
58. Marangoni A, Aldini R, Sambri V, et al. Uptake and killing of Leptospira interrogans and Borrelia burgdorferi, spirochetes pathogenic to humans, by reticuloendothelial cells in perfused rat liver. Infect Immun 2000; 68:5408-5411.
59. Merien F, Baranton G, Perolat P. Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect Immun 1997; 65:729-738.
60. Thomas DD, Higbie LM. In vitro association of leptospires with host cells. Infect Immun 1990; 58:581-585.
61. Cinco M, Domenis R, Perticarari S, et al. Interaction of leptospires with murine microglial cells. The new microbiologica 2006; 29:193-199.
62. Ito T, Yanagawa R. Leptospiral attachment to four structural components of extracellular matrix. Nippon Juigaku Zasshi 1987; 49:875-882.
63. Ito T, Yanagawa R. Leptospiral attachment to extracellular matrix of mouse fibroblast (L929) cells. Vet Microbiol 1987; 15:89-96.
64. Barbosa AS, Abreu PA, Neves FO, et al. A newly identified leptospiral adhesin mediates attachment to laminin. Infect Immun 2006; 74:6356-6364. Barbosa et al. identified Lsa24, a new leptospiral adhesin that binds to laminin, indicating its involvement in host-pathogen interaction.
65. Hamburger ZA, Brown MS, Isberg RR, Bjorkman PJ. Crystal structure of invasin: a bacterial integrin-binding protein. Science 1999; 286:291-295.
66. Isberg RR, Voorhis DL, Falkow S. Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 1987; 50:769-778.
67. Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 1990; 87: 7839-7843.
68. Finlay BB, Ruschkowski S, Kenny B, et al. Enteropathogenic E. coli exploitation of host epithelial cells. Ann N Y Acad Sci 1996; 797:26-31.
69. Francis CL, Starnbach MN, Falkow S. Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions. Mol Microbiol 1992; 6:3077-3087.
70. Francis CL, Ryan TA, Jones BD, et al. Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria. Nature 1993; 364:639-642.
71. Goldberg MB. Actin-based motility of intracellular microbial pathogens. Microbiol Mol Biol Rev 2001; 65:595-626; table of contents.
72. Goosney DL, Knoechel DG, Finlay BB. Enteropathogenic E. coli, Salmonella, and Shigella: masters of host cell cytoskeletal exploitation. Emerg Infect Dis 1999; 5:216-223.
73. Isberg RR, Leong JM. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990; 60:861-871.
74. Sansonetti PJ. Genetic and molecular basis of epithelial cell invasion by Shigella species. Rev Infect Dis 1991; 13 (Suppl 4):S285-S292.
75. Young VB, Falkow S, Schoolnik GK. The invasin protein of Yersinia enterocolitica: internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton. J Cell Biol 1992; 116: 197-207.
76. Comstock LE, Thomas DD. Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect Immun 1989; 57:1626-1628.
77. Thomas DD, Navab M, Haake DA, et al. Treponema pallidum invades intercellular junctions of endothelial cell monolayers. Proc Natl Acad Sci USA 1988; 85:3608-3612.
78. Miller NG, Froehling RC, White RJ. Activity of leptospires and their products on L cell monolayers. Am J Vet Res 1970; 31:371-377.
79. Rose GW, Eveland WC, Ellinghausen HC. Mechanisms of tissue cell penetration by Leptospira pomona: phagocytosis of leptospires in vitro. Am J Vet Res 1966; 27:503-511.
80. Tsuchimoto M, Niikura M, Ono E, et al. Leptospiral attachment to cultured cells. Zentralbl Bakteriol Mikrobiol Hyg [A] 1984; 258:268-274.
81. Grier T. The difficulty of culturing spirochetes. 2000. http://www.lymealliance.org/medical/lab/lab_7.php 2000 [Last accessed 19 March 2007].
82. Brenot A, Trott D, Saint Girons I, Zuerner R. Penicillin-binding proteins in Leptospira interrogans. Antimicrob Agents Chemother 2001; 45:870-877.
83. Girons IS, Bourhy P, Ottone C, et al. The LE1 bacteriophage replicates as a plasmid within Leptospira biflexa: construction of an L. biflexa-Escherichia coli shuttle vector. J Bacteriol 2000; 182:5700-5705.
84. Tchamedeu Kameni AP, Couture-Tosi E, Saint-Girons I, Picardeau M. Inactivation of the spirochete recA gene results in a mutant with low viability and irregular nucleoid morphology. J Bacteriol 2002; 184:452-458.
85. Picardeau M, Brenot A, Saint Girons I. First evidence for gene replacement in Leptospira spp. Inactivation of L. biflexa flaB results in nonmotile mutants deficient in endoflagella. Mol Microbiol 2001; 40:189-199.
86. Bauby H, Saint Girons I, Picardeau M. Construction and complementation of the first auxotrophic mutant in the spirochaete Leptospira meyeri. Microbiology 2003; 149:689-693.
87. Falkow S. Perspectives series: host/pathogen interactions. Invasion and intracellular sorting of bacteria: searching for bacterial genes expressed during host/pathogen interactions. J Clin Invest 1997; 100:239-243.
88. Chiang SL, Mekalanos JJ. Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol Microbiol 1998; 27:797-805.
89. Haake DA. Spirochaetal lipoproteins and pathogenesis. Microbiology 2000; 146:1491-1504.
90. Nally JE, Timoney JF, Stevenson B. Temperature-regulated protein synthesis by Leptospira interrogans. Infect Immun 2001; 69:400-404.
91. Handfield M, Brady LJ, Progulske-Fox A, Hillman JD. IVIAT: a novel method to identify microbial genes expressed specifically during human infections. Trends Microbiol 2000; 8:336-339.
92. Handfield M, Levesque RC. Strategies for isolation of in vivo expressed genes from bacteria. FEMS Microbiol Rev 1999; 23:69-91.
93. Faine S. Leptospira and leptospirosis. Boca Raton, FL: CRD; 1994.
94. Artiushin S, Timoney JF, Nally J, Verma A. Host-inducible immunogenic sphingomyelinase-like protein, Lk73.5, of Leptospira interrogans. Infect Immun 2004; 72:742-749.
95. DiRita VJ, Mekalanos JJ. Genetic regulation of bacterial virulence. Annu Rev Genet 1989; 23:455-482.
96. Mahan MJ, Tobias JW, Slauch JM, et al. Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host. Proc Natl Acad Sci USA 1995; 92:669-673.
97. Ku YW, McDonough SP, Palaniappan RU, et al. Novel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesis. Infect Immun 2005; 73:8194-8203.
98. Valdivia RH, Falkow S. Fluorescence-based isolation of bacterial genes expressed within host cells. Science 1997; 277:2007-2011.
99. Valdivia RH, Falkow S. Flow cytometry and bacterial pathogenesis. Curr Opin Microbiol 1998; 1:359-363.
100. Ang S, Lee CZ, Peck K, et al. Acid-induced gene expression in Helicobacter pylori: study in genomic scale by microarray. Infect Immun 2001; 69:1679-1686.
101. Salama N, Guillemin K, McDaniel TK, et al. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci USA 2000; 97:14668-14673.
102. Sauvonnet N, Pradet-Balade B, Garcia-Sanz JA, Cornelis GR. Regulation of mRNA expression in macrophages after Yersinia enterocolitica infection. Role of different Yop effectors. J Biol Chem 2002; 277:25133-25142; Epub 2002 May 2.
103. Brooks CS, Hefty PS, Jolliff SE, Akins DR. Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect Immun 2003; 71:3371-3383.
104. Liang B, Mamula MJ. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens. Cell Mol Life Sci 2000; 57:561-568.
105. Revel AT, Talaat AM, Norgard MV. DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci USA 2002; 99:1562-1567.
106. Binnicker MJ, Williams RD, Apicella MA. Infection of human urethral epithelium with Neisseria gonorrhoeae elicits an upregulation of host antiapoptotic factors and protects cells from staurosporine-induced apoptosis. Cell Microbiol 2003; 5:549-560.
107. Mahony JB. Chlamydiae host cell interactions revealed using DNA microarrays. Ann N Y Acad Sci 2002; 975:192-201.
108. Schnappinger D, Ehrt S, Voskuil MI, et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J Exp Med 2003; 198:693-704.
109. Voskuil MI, Schnappinger D, Visconti KC, et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 2003; 198:705-713.
110. Yang HL, Zhu YZ, Qin JH, et al. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. BMC Genomics 2006; 7:293.
111. Haas G, Karaali G, Ebermayer K, et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2002; 2:313-324.
112. Nouwens AS, Beatson SA, Whitchurch CB, et al. Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1. Microbiology 2003; 149:1311-1322.
113. Ziebandt AK, Weber H, Rudolph J, et al. Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B. Proteomics 2001; 1:480-493.
114. Lo M, Bulach DM, Powell DR, et al. Effects of temperature on gene expression patterns in Leptospira interrogans serovar Lai as assessed by whole-genome microarrays. Infect Immun 2006; 74:5848-5859.
115. Louvel H, Bommezzadri S, Zidane N, et al. Comparative and functional genomic analyses of iron transport and regulation in Leptospira spp. J Bacteriol 2006; 188:7893-7904. This study presents a comparative genomics analysis of iron uptake systems and their regulation in the saprophyte L. biflexa and the pathogen L. interrogans.
116. Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999; 284:1520-1523.
117. Cole ST. Comparative and functional genomics of the Mycobacterium tuberculosis complex. Microbiology 2002; 148:2919-2928.
118. Cummings CA, Brinig MM, Lepp PW, et al. Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. J Bacteriol 2004; 186:1484-1492.
119. Hickey PW, Demers D. Leptospirosis. Emedicine http://www.emedicine.com/ ped/topic1298.htm [Accessed 15 March 2007].
120. Bolin CA, Alt DP. Use of a monovalent leptospiral vaccine to prevent renal colonization and urinary shedding in cattle exposed to Leptospira borgpetersenii serovar hardjo. Am J Vet Res 2001; 62:995-1000.
121. Brown PD, Carrington DG, Gravekamp C, et al. Direct detection of leptospiral material in human postmortem samples. Res Microbiol 2003; 154:581-586.
122. McBride AJ, Athanazio DA, Reis MG, et al. Leptospirosis. Curr Opin Infect Dis 2005; 18:376-386.
123. Blacksell SD, Smythe L, Phetsouvanh R, et al. Limited diagnostic capacities of two commercial assays for the detection of Leptospira immunoglobulin m antibodies in Laos. Clin Vaccine Immunol 2006; 13:1166-1169.
124. Bomfim MR, Ko A, Koury MC. Evaluation of the recombinant LipL32 in enzyme-linked immunosorbent assay for the serodiagnosis of bovine leptospirosis. Vet Microbiol 2005; 109:89-94.
125. Boonyod D, Poovorawan Y, Bhattarakosol P, et al. LipL32, an outer membrane protein of Leptospira, as an antigen in a dipstick assay for diagnosis of leptospirosis. Asian Pac J Allergy Immunol 2005; 23:133-141.
126. Dey S, Mohan CM, Kumar TM, et al. Recombinant LipL32 antigen-based single serum dilution ELISA for detection of canine leptospirosis. Vet Microbiol 2004; 103:99-106.
127. Mariya R, Chaudhary P, Kumar AA, et al. Evaluation of a recombinant LipL41 antigen of Leptospira interrogans serovar Canicola in ELISA for serodiagnosis of bovine leptospirosis. Comp Immunol Microbiol Infect Dis 2006; 29:269-277.
128. Okuda M, Sakai Y, Matsuuchi M, et al. Enzyme-linked immunosorbent assay for the detection of canine Leptospira antibodies using recombinant OmpL1 protein. J Vet Med Sci 2005; 67:249-254.
129. Surujballi O, Mallory M. An indirect enzyme linked immunosorbent assay for the detection of bovine antibodies to multiple Leptospira serovars. Can J Vet Res 2004; 68:1-6.
130. Suwimonteerabutr J, Chaicumpa W, Saengjaruk P, et al. Evaluation of a monoclonal antibody-based dot-blot ELISA for detection of Leptospira spp in bovine urine samples. Am J Vet Res 2005; 66:762-766.
131. Fonseca Cde A, Teixeira MM, Romero EC, et al. Leptospira DNA detection for the diagnosis of human leptospirosis. J Infect 2006; 52:15-22.
132. Kee SH, Kim IS, Choi MS, Chang WH. Detection of leptospiral DNA by PCR. J Clin Microbiol 1994; 32:1035-1039.
133. Merien F, Perolat P, Mancel E, et al. Detection of Leptospira DNA by polymerase chain reaction in aqueous humor of a patient with unilateral uveitis. J Infect Dis 1993; 168:1335-1336.
134. Morey RE, Galloway RL, Bragg SL, et al. Species-specific identification of Leptospiraceae by 16S rRNA gene sequencing. J Clin Microbiol 2006; 44:3510-3516.
135. Jouglard SD, Simionatto S, Seixas FK, et al. Nested polymerase chain reaction for detection of pathogenic leptospires. Can J Microbiol 2006; 52:747-752.
136. La Scola B, Bui LT, Baranton G, et al. Partial rpoB gene sequencing for identification of Leptospira species. FEMS Microbiol Lett 2006; 263:142-147.
137. Leon A, Pronost S, Tapprest J, et al. Identification of pathogenic Leptospira strains in tissues of a premature foal by use of polymerase chain reaction analysis. J Vet Diagn Invest 2006; 18:218-221.
138. Liu D, Lawrence ML, Austin FW, et al. PCR detection of pathogenic Leptospira genomospecies targeting putative transcriptional regulator genes. Can J Microbiol 2006; 52:272-277.
139. Palaniappan RU, Chang YF, Chang CF, et al. Evaluation of lig-based conventional and real time PCR for the detection of pathogenic leptospires. Mol Cell Probes 2005; 19:111-117.
140. Reitstetter RE. Development of species-specific PCR primer sets for the detection of Leptospira. FEMS Microbiol Lett 2006; 264:31-39.
141. Romero EC, Yasuda PH. Molecular characterization of Leptospira sp. strains isolated from human subjects in Sao Paulo, Brazil using a polymerase chain reaction-based assay: a public health tool. Mem Inst Oswaldo Cruz 2006; 101:373-378.
142. Slack A, Symonds M, Dohnt M, Smythe L. An improved multiple-locus variable number of tandemrepeats analysis for Leptospira interrogans serovar Australis: a comparison with fluorescent amplified fragment length polymorphism analysis and its use to redefine the molecular epidemiology of this serovar in Queensland, Australia. J Med Microbiol 2006; 55:1549-1557.
143. Kositanont U, Rugsasuk S, Leelaporn A, et al. Detection and differentiation between pathogenic and saprophytic Leptospira spp. by multiplex polymerase chain reaction. Diagn Microbiol Infect Dis 2007; 57:117-122.
144. Salaun L, Merien F, Gurianova S, et al. Application of multilocus variable-number tandem-repeat analysis for molecular typing of the agent of leptospirosis. J Clin Microbiol 2006; 44:3954-3962.
145. Naiman BM, Alt D, Bolin CA, et al. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect Immun 2001; 69:7550-7558.
146. Naiman BM, Blumerman S, Alt D, et al. Evaluation of type 1 immune response in naive and vaccinated animals following challenge with Leptospira borgpetersenii serovar Hardjo: involvement of WC1(+) gammadelta and CD4 T cells. Infect Immun 2002; 70:6147-6157.
147. Vernel-Pauillac F, Merien F. Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect Immun 2006; 74:4172-4179. This is the first paper to establish that pathogenic leptospires can stimulate the production of type 1 cytokines in vivo.
148. Alves VA, Gayotto LC, De Brito T, et al. Leptospiral antigens in the liver of experimentally infected guinea pig and their relation to the morphogenesis of liver damage. Exp Toxicol Pathol 1992; 44:425-434.
149. Anderson LJ. Experimental reproduction of canine interstitial nephritis. J Comp Pathol 1967; 77:413-418.
150. Keenan KP, Alexander AD, Mongomery CA Jr. Pathogenesis of experimental Leptospira interrogans, serovar bataviae, infection in the dog: microbiological, clinical, hematologic, and biochemical studies. Am J Vet Res 1978; 39:449-454.
151. Oliva R, Infante JF, Gonzalez M, et al. Pathologic-clinical characterization of leptospirosis in a golden Syrian hamster model. Arch Med Res 1994; 25:165-170.
152. Nally JE, Chantranuwat C, Wu XY, et al. Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 2004; 164:1115-1127.
153. Ruhl-Fehlert CI, Brem S, Feller W, et al. Clinical, microbiological and pathological observations in laboratory beagle dogs infected with leptospires of the serogroup Sejroe. Exp Toxicol Pathol 2000; 52:201-207.
154. Taylor PL, Hanson LE, Simon J. Serologic, pathologic, and immunologic features of experimentally induced leptospiral nephritis in dogs. Am J Vet Res 1970; 31:1033-1049.
155. Yoder HW, Bergman EN, Gleiser CA. Experimental canine leptospirosis. IV. Evaluation of selected antibiotics in the therapy of acute experimental Leptospira icterohemorrhagiae infections in immature dogs. J Infect Dis 1957; 100:257-267.
156. Randall R, Cooper HK. The golden hamster (Cricetus auratus) as a test animal for the diagnosis of leptospirosis. Science 1944; 100:133-134.
157. Takashima I, Yanagawa R. Immunizing effects of structural components of Leptospira icterohaemorrhagiae. Zentralbl Bakteriol [Orig A] 1975; 233:93-98.
158. Zeigler JA, Jones RH, Kubica K. Immunization against leptospirosis: vaccine trials with heat-killed whole cell and outer envelope antigens in hamsters. Bull Pan Am Health Org 1976; 10:126-130.
159. Branger C, Sonrier C, Chatrenet B, et al. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun 2001; 69:6831-6838.
160. Palaniappan RU, McDonough SP, Divers TJ, et al. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 2006; 74:1745-1750. This paper describes the protective efficacy of LigA in hamster model; it also suggests that Lig proteins can stimulate cell-mediated immunity.
161. Sonrier C, Branger C, Michel V, et al. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 2000; 19:86-94.
162. Koizumi N, Watanabe H. Identification of a novel antigen of pathogenic Leptospira spp. that reacted with convalescent mice sera. J Med Microbiol 2003; 52:585-589.
163. Boom WH. Gammadelta T cells and Mycobacterium tuberculosis. Microbes Infect 1999; 1:187-195.
164. Ho M, Webster HK, Tongtawe P, et al. Increased gamma delta T cells in acute Plasmodium falciparum malaria. Immunol Lett 1990; 25:139-141.
165. Hoft DF, Brown RM, Roodman ST. Bacille Calmette-Guerin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J Immunol 1998; 161:1045-1054.
166. Huber SA, Budd RC, Rossner K, Newell MK. Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy. Ann N Y Acad Sci 1999; 887:181-190.
167. Hviid L, Akanmori BD, Loizon S, et al. High frequency of circulating gamma delta T cells with dominance of the v(delta)1 subset in a healthy population. Int Immunol 2000; 12:797-805.
168. Hviid L, Kurtzhals JA, Adabayeri V, et al. Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria. Infect Immun 2001; 69:3190-3196.
169. Hviid L, Kurtzhals JA, Dodoo D, et al. The gamma/delta T-cell response to Plasmodium falciparum malaria in a population in which malaria is endemic. Infect Immun 1996; 64:4359-4362.
170. Morita CT, Beckman EM, Bukowski JF, et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995; 3:495-507.
171. Rogers AN, Vanburen DG, Hedblom E, et al. Function of ruminant gammadelta T cells is defined by WC1.1 or WC1.2 isoform expression. Vet Immunol Immunopathol 2005; 108:211-217.
172. Rappuoli R, Covacci A. Reverse vaccinology and genomics. Science 2003; 302:602.
173. Forns X, Payette PJ, Ma X, et al. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology 2000; 32:618-625.
174. Chow YH, Chiang BL, Lee YL, et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol 1998; 160:1320-1329.
175. Larsen DL, Dybdahl-Sissoko N, McGregor MW, et al. Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. J Virol 1998; 72:1704-1708.
176. Gurunathan S, Sacks DL, Brown DR, et al. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med 1997; 186:1137-1147.